259 related articles for article (PubMed ID: 29032925)
1. Current status of the etiology of candidiasis in Mexico.
Reyes-Montes MDR; Duarte-Escalante E; Martínez-Herrera E; Acosta-Altamirano G; Frías-De León MG
Rev Iberoam Micol; 2017; 34(4):203-210. PubMed ID: 29032925
[TBL] [Abstract][Full Text] [Related]
2. [Candida auris: estrategias y retos para prevenir un brote].
Zuluaga-Rodríguez A
Biomedica; 2020 Mar; 40(1):5-10. PubMed ID: 32220157
[No Abstract] [Full Text] [Related]
3. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
4. Importance of Candida species other than Candida albicans as opportunistic pathogens.
Coleman DC; Rinaldi MG; Haynes KA; Rex JH; Summerbell RC; Anaissie EJ; Li A; Sullivan DJ
Med Mycol; 1998; 36 Suppl 1():156-65. PubMed ID: 9988504
[TBL] [Abstract][Full Text] [Related]
5. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
[TBL] [Abstract][Full Text] [Related]
6. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of candidaemia and invasive candidiasis. A changing face.
Quindós G
Rev Iberoam Micol; 2014; 31(1):42-8. PubMed ID: 24270071
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
Treviño-Rangel Rde J; Garza-González E; González JG; Bocanegra-García V; Llaca JM; González GM
Med Mycol; 2012 Oct; 50(7):781-4. PubMed ID: 22493945
[TBL] [Abstract][Full Text] [Related]
9. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
[TBL] [Abstract][Full Text] [Related]
11. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
[TBL] [Abstract][Full Text] [Related]
12. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
13. The Candida auris Alert: Facts and Perspectives.
Lamoth F; Kontoyiannis DP
J Infect Dis; 2018 Jan; 217(4):516-520. PubMed ID: 29390110
[No Abstract] [Full Text] [Related]
14. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
15. Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F; Lockhart SR; Berkow EL; Calandra T
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i4-i13. PubMed ID: 29304207
[TBL] [Abstract][Full Text] [Related]
16. Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options.
de Cássia Orlandi Sardi J; Silva DR; Soares Mendes-Giannini MJ; Rosalen PL
Microb Pathog; 2018 Dec; 125():116-121. PubMed ID: 30205192
[TBL] [Abstract][Full Text] [Related]
17. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients.
Zer Y; Balci I; Meriç G
New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological typing methods for mycoses.
Pfaller MA
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S4-10. PubMed ID: 1562694
[TBL] [Abstract][Full Text] [Related]
19. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
20. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Forsberg K; Woodworth K; Walters M; Berkow EL; Jackson B; Chiller T; Vallabhaneni S
Med Mycol; 2019 Jan; 57(1):1-12. PubMed ID: 30085270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
